The collaboration as a “step forward” in cancer research and expressed optimism that the group would “unlock the potential of cancer vaccines and bring hope to patients worldwide.”
In addition, the researchers report that the university is already developing several potential preventative cancer vaccines, such as “LynchVax” for individuals with Lynch syndrome,
A genetic disorder that raises the risk of developing certain cancers; “OvarianVax,” which “teaches” the immune system to identify and combat ovarian cancer in its early stages;
And “LungVax,” which may prevent or postpone the onset of cancer in individuals at risk of developing certain types of lung cancer.
